This paper is only available as a PDF. To read, Please Download here.
Abstract
The drive to contain the rising cost of medical care provides numerous challenges
to blood bankers. Not the least of these is the opportunity to improve quality of
care while reducing the cost thereof. This paper explores various cost-reduction strategies,
focusing primarily on those applicable to small and medium-sized transfusion services,
and demonstrates methods by which they can be implemented to yield improved patient
care.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Transfusion and Apheresis ScienceAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Transfusion therapy: improved patient care and resource utilization.Transfusion. 1993; 33: 341-347
- A prospective study to determine the safety of omitting the antiglobulin crossmatch from pretransfusion testing.Br J Haematol. 1992; 81: 579-584
- Experience with the routine use of an abbreviated crossmatch.Am J Clin Pathol. 1984; 82: 178-181
- Frequency of delayed hemolytic transfusion reactions following antibody screening and immediate-spin cross-matching.Transfusion. 1992; 32: 814-817
- The sensitivity and specificity of the immediate-spin crossmatch.Transfusion. 1989; 29: 99-102
- Additional limitations of the immediate spin crossmatch to detect ABO incompatibility.Am J Clin Pathol. 1987; 87: 677
- Red cell compatibility testing: A perspective for the future.Transfus Med Rev. 1996; 10: 118-130
- Experience with a cost-effective cross-match protocol.J Am Med Assoc. 1985; 254: 93-95
- Are there better ways than the crossmatch to demonstrate ABO incompatibility?.Transfusion. 1991; 31: 192-194
- Standards for Blood Banks and Transfusion Services.17th edn. American Association of Blood Banks, Bethesda, MD1996
- Safety in transfusion practice: Is it safe to eliminate the major crossmatch for selected patients?.Arch Pathol Lab Med. 1989; 113: 270-272
- Risk of ABO and non-ABO incompatibility using type and screen and electronic crossmatch.Transfusion. 1991; 31 (Abstr, Suppl): 60S
- The evaluation of a positive direct antiglobulin test in pretransfusion testing.Transfusion. 1980; 20: 17-23
- The evaluation of a positive direct antiglobulin test (autocontrol) in pretransfusion testing revisited.Transfusion. 1986; 26: 220-224
- The efficacy of performing red cell elution studies in pretransfusion testing of patients with positive direct antiglobulin tests.Transfusion. 1986; 26: 225-226
- Blood transfusion options: improving outcomes and reducing costs.Arch Pathol Lab Med. 1997; 121: 40-47
- Cost-effectiveness of routine blood type and screen testing before elective laparoscopy.Obstet Gynecol. 1995; 86: 346-348
- Pre-cesarean blood bank orders: A safe and less expensive approach.Obstet Gynecol. 1996; 87: 912-916
- Blood transfusion practice in gynaecology and obstetrics: Retrospective audit.Vox Sang. 1994; 67: 323-325
- A strategy to reduce inappropriate red blood cell transfusion.Med J Aust. 1994; 160: 721-722
- The effect of provider education on blood utilization practices.Am J Obstet Gynecol. 1993; 169: 1240-1245
- A non computer-dependent prospective review of blood and blood component utilization.Transfusion. 1992; 32: 260-265
- The risk of transfusion-transmitted viral infections.N Engl J Med. 1996; 334: 1685-1690
- The necessary and unnecessary transfusion: a critical review of reported appropriateness rates and criteria for red cell transfusions.Transfusion. 1994; 34: 110-115
- Transfusion practice in medical patients.Arch Intern Med. 1993; 153: 2375-2380
- Economic impact of inappropriate blood transfusions in coronary artery bypass surgery.Am J Med. 1993; 94: 509-514
- Blood transfusion costs: A multicenter study.Transfusion. 1991; 31: 318-323
- The hospital cost (fiscal year 1991/1992) of a simple perioperative allogeneic red blood cell transfusion during elective surgery at Duke University.Anesth Analg. 1994; 79: 629-637
- A controlled trial of educational outreach to improve blood transfusion practice.J Am Med Assoc. 1993; 270: 961-966
- Are retrospective peer-review transfusion monitoring systems effective in reducing red blood cell utilization?.Arch Pathol Lab Med. 1996; 120: 810-816
- Safety of stringent prophylactic platelet transfusion policy for patients with acute leukemia.Lancet. 1991; 338: 1223-1226
- The 10,000/iL trigger compared to 20,000/μL for prophylactic platelet transfusion in AML: A prospective comparative multicenter study [abstract].Blood. 1996; 88: 443a
- Platelet transfusion therapy.Clin Lab Med. 1996; 16: 797-816
- Clinical perspectives of platelet transfusion: Defining the optimal dose.J Clin Apheresis. 1995; 10: 124-127
- Four pooled platelet concentrates (PC) have therapeutic efficacy (TE) of apheresis platelets after optimization by continuous quality improvement [Abstract Suppl].Transfusion. 1995; 35: 8S
- Delayed alloimmunization using random single donor platelet transfusions: A prospective study in thrombocytopenic patients with acute leukemia.Blood. 1983; 62: 473-479
- The leukodepletion of cellular blood products in the prevention of HLA-alloimmunization and refractoriness to allogeneic platelet transfusions.Blood. 1995; 85: 603-606
- The efficacy of leukodepletion to improve platelet transfusion response: A critical appraisal of clinical studies.Transfus Med Rev. 1994; 8: 15-28
- Prevention of alloimmunization against platelets.Blood. 1991; 77: 1-4
- Bedside filtration of blood products in the prevention of HLA alloimmunization-A prospective randomized study.Blood. 1994; 83: 3028-3035
- Leukocyte depletion of random single-donor platelet transfusions does not prevent secondary human leukocyte antigen-alloimmunization and refractoriness: A randomized prospective study.Blood. 1995; 85: 824-828
- Report on results of Trial to Reduce Alloimmunization to Platelets.in: Annual Meeting, American Association of Blood Banks, Orlando, FLOctober 1996
- Is white cell reduction cost-effective?.Transfusion. 1993; 33: 626-628
- A comparison of filtered leukocytereduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant.Blood. 1995; 86: 3598-3603
- Cost-effectiveness of white cell-reduction filters in treatment of adult acute myelogenous leukemia.Transfusion. 1993; 33: 665-670
- Leukocyte-depleted-ABO-identical blood components in the treatment of hematologic malignancies: A cost analysis.Am J Hematol. 1995; 48: 108-115
- Controversies in transfusion medicine: Should a febrile transfusion response occasion the return of the blood component to the blood bank?.Con Transfusion. 1994; 34: 353-355
- Special insert: Proposed changes to standards for blood banks and transfusion services.News Briefs. 1997; 19: 10-14
- Controversies in transfusion medicine: Should a febrile transfusion response occasion the return of the blood component to the blood bank?.Pro Transfusion. 1994; 34: 356-358
- Color Atlas and Textbook of Diagnostic Microbiology.in: 4th edn. JB Lippincott Company, Philadelphia, PA1992: 95
Article info
Identification
Copyright
© 1997 Published by Elsevier Inc.
